Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xingqi Daozhi Decoction is a Traditional Chinese Medicine (TCM) formula developed by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine, specifically for the treatment of functional constipation (Qi-stagnation type). The decoction is composed of several botanical ingredients, including *Magnolia officinalis*, *Citrus aurantium*, and *Aucklandia lappa*, which work synergistically to promote gastrointestinal motility and alleviate abdominal distension. Its mechanism of action involves the modulation of the enteric nervous system, specifically by increasing the expression of excitatory neurotransmitters like serotonin (5-HT) and substance P, while decreasing inhibitory factors such as vasoactive intestinal peptide (VIP). Clinical research indicates that the formula effectively improves bowel movement frequency and stool consistency, making it a significant therapeutic option in integrated medicine for chronic digestive disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xing qi dao zhi decoction.